Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

被引:12
|
作者
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构
[1] Clin Univ St Luc, Inst Rech Expt & Clin, Pole Rech Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Inst Rech Expt & Clin, Div Cardiol, Pole Rech Cardiovasc, B-1200 Brussels, Belgium
关键词
FGF-23; Galectin-3; ST2; NT-proBNP; BNP; Biomarker; Heart failure; Prognosis; EXPRESSION; PREDICTOR;
D O I
10.1016/j.ijcard.2015.04.074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:185 / 187
页数:3
相关论文
共 50 条
  • [1] Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure
    Mueller, Thomas
    Gegenhuber, Alfons
    Leitner, Isabella
    Poelz, Werner
    Haltmayer, Meinhard
    Dieplinger, Benjamin
    CLINICA CHIMICA ACTA, 2016, 463 : 158 - 164
  • [2] Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure
    Yamamoto, Masayoshi
    Seo, Yoshihiro
    Ishizua, Tomoko
    Nakagawa, Daishi
    Sato, Kimi
    Machino-Ohtsuka, Tomoko
    Nishi, Isao
    Hamada-Harimura, Yoshie
    Sai, Seika
    Sugano, Akinori
    Baba, Masako
    Higuchi, Haruhiko
    Aonuma, Kazutaka
    Ohte, Nobuyuki
    Ieda, Masaki
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (11) : 1240 - 1250
  • [3] Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure
    Zhang, Rongcheng
    Zhang, Yuhui
    An, Tao
    Guo, Xiao
    Yin, Shijie
    Wang, Yunhong
    Januzzi, James L.
    Cappola, Thomas P.
    Zhang, Jian
    BIOMARKERS IN MEDICINE, 2015, 9 (05) : 433 - 441
  • [4] Exploring the Causal Effects of Circulating ST2 and Galectin-3 on Heart Failure Risk: A Mendelian Randomization Study
    Wang, Xizhi
    Wang, Xingchen
    Zhu, Jun
    Liu, Yu
    Zhuang, Lenan
    Zhang, Zhe
    Zhong, Danfeng
    Zhang, Wenbin
    Lai, Dongwu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] Soluble ST2 and Galectin-3 and Progression of CKD
    Alam, Mariam L.
    Katz, Ronit
    Bellovich, Keith A.
    Bhat, Zeenat Y.
    Brosius, Frank C.
    de Boer, Ian H.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Hawkins, Jennifer J.
    Himmelfarb, Jonathan
    Kestenbaum, Bryan R.
    Kretzler, Matthias
    Robinson-Cohen, Cassianne
    Steigerwalt, Susan P.
    Tuegel, Courtney
    Bansal, Nisha
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (01): : 103 - 111
  • [6] Association of ST2, Galectin-3, and NT- Probnp in Elderly Hypertensive Patients and Heart Failure with a Preserved Ejection Fraction
    Li, Ping
    Wang, Lin
    Yang, Fan
    Yu, Hui
    Xiao, Fan Kai
    CURRENT VASCULAR PHARMACOLOGY, 2025,
  • [7] Association of suPAR, ST2, and galectin-3 with eGFR decline and mortality in patients with advanced heart failure with reduced ejection fraction
    Roehm, Bethany
    McAdams, Meredith
    Gordon, Jonathan
    Zhang, Song
    Xu, Pin
    Grodin, Justin L.
    Hedayati, S. Susan
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 640 - 651
  • [8] Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results
    Wu, Alan H. B.
    Wians, Frank
    Jaffe, Allan
    AMERICAN HEART JOURNAL, 2013, 165 (06) : 995 - 999
  • [9] Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
    Gruson, Damien
    Lepoutre, Thibault
    Ahn, Sylvie A.
    Rousseau, Michel F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : E250 - E252
  • [10] Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction
    Gruson, Damien
    Ferracin, Benjamin
    Ahn, Sylvie A.
    Rousseau, Michel F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 270 - 273